曼尼托在冠状动脉旁路移植后对心脏功能和术后心律不整的影响:一项随机对照试验
Masumeh Hemmati Maslakpak1, Sohrab Negargar2, Ali Farbod3
1Nursing and Midwifery School, Maternal and Childhood Obesity Research Center, Urmia University of Medical, Urmia, Iran.
Journal of cardiothoracic surgery
|October 22, 2025
概括
在冠状动脉旁路移植 (CABG) 期间服用曼尼托尔显示,心室的发生率显著降低. 然而,这项单中心研究需要进行更大规模的试验,以确认CABG后对其他心脏结果的影响.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 术后心脏功能障碍和心律失常在心脏手术后很常见.
- 这些并发症增加了死亡率,住院时间,医疗费用,并降低了患者的生活质量.
- 冠状动脉旁路移植 (CABG) 是一种主要的心脏手术程序,这些并发症是令人担忧的.
研究的目的:
- 为了研究曼尼托尔对心脏功能的影响.
- 评估CABG后手术后心律失常的发生率.
- 为了确定曼尼托尔是否会影响诸如心室动之类的结果.
主要方法:
- 进行了一项单中心,双盲,随机对照试验.
- 90名接受选择性式CABG的患者被随机分配给接受曼尼托尔或乳酸林格溶液.
- 手术后的评估包括心脏酶,心律失常的发生率和左心室喷射率.
主要成果:
- 在基线人口统计学,心脏酶,左心室喷射率,心房动或心房动脉冲动之间没有发现显著差异.
- 曼尼托尔 (Mannitol) 组显示,心室的发病率在统计上显著降低 (4.4%对17.8%,p=0.045).
- 曼尼托尔和对照组之间的30天死亡率相似.
结论:
- 在CABG期间服用曼尼托尔与心室的发病率较低有关.
- 这项单中心研究在检测其他结果差异方面存在局限性.
- 需要进行更大规模的多中心研究来验证这些发现,并探索曼尼托在心脏手术中的其他潜在益处.
相关概念视频
01:25Mitral Regurgitation III: Medical Management
274
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
274
01:26Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
283
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
283
01:26Mitral Stenosis III: Medical Management
245
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
245
01:28Mitral Regurgitation IV: Nursing Management
303
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
303
01:27Mitral Stenosis IV: Nursing Management
246
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
246